Holen Sie sich die Stockscreener-App
11.40
3.92%
0.43
Handel nachbörslich:
11.43
0.03
+0.26%
Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.91%
18.17
|
19.31 | 21.57 | 20.42 | 16.69 |
| Operating Income/Loss |
5.91%
-18.17
|
-19.31 | -21.57 | -20.42 | -16.69 |
| Income/Loss From Continuing Operations Before Tax |
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
| Income/Loss From Continuing Operations After Tax |
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
|
Net Income/Loss
|
5.88%
-16.00
|
-17.00 | -19.08 | -17.71 | -13.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.17%
0.4734
|
56.95 | 56.86 | 56.76 | 0.0318 |
| Diluted Average Shares |
99.17%
0.4734
|
56.95 | 56.86 | 56.76 | 0.0318 |
| Basic Earnings Per Share |
10.00%
-0.27
|
-0.30 | -0.34 | -0.31 | -0.24 |
| Diluted Earnings Per Share |
10.00%
-0.27
|
-0.30 | -0.34 | -0.31 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):